Promoting Innovation in Antimicrobial Resistance: prevention, diagnosis and treatment

This event highlights innovation in antimicrobial resistance (AMR) across prevention, diagnosis, and treatment. It examines how incentive models can better support the development of new antimicrobials, diagnostics, vaccines, and infection prevention tools while ensuring stewardship, access, and equity. Bringing together policymakers, researchers, industry, and civil society, the discussion will explore how responsibilities and incentives can be aligned to strengthen the AMR innovation ecosystem.

What to expect on the day:

• Hybrid event.

  
  

  Opening Remarks

• Rodrigo Scotini, Executive Director, IDA

• Setting the scene: why innovation incentives must support prevention, stewardship, and equitable access.